CCN5/WISP-2: A micromanager of breast cancer progression
about
Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth.MicroRNA-10b regulates epithelial-mesenchymal transition by modulating KLF4/Notch1/E-cadherin in cisplatin-resistant nasopharyngeal carcinoma cells.WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathwaysHypoxia-inducible factor-mediated induction of WISP-2 contributes to attenuated progression of breast cancer.CCN family of proteins: critical modulators of the tumor cell microenvironment.Loss of WISP2/CCN5 in estrogen-dependent MCF7 human breast cancer cells promotes a stem-like cell phenotype.Glucocorticoids induce CCN5/WISP-2 expression and attenuate invasion in oestrogen receptor-negative human breast cancer cells.Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review).Role of CCN5 (WNT1 inducible signaling pathway protein 2) in pancreatic islets.Exosomes in carcinogenesis: molecular palkis carry signals for the regulation of cancer progression and metastasis.Human pancreatic cancer progression: an anarchy among CCN-siblings.Decreased TIP30 promotes Snail-mediated epithelial-mesenchymal transition and tumor-initiating properties in hepatocellular carcinoma.The matricellular protein CCN1/Cyr61 is a critical regulator of Sonic Hedgehog in pancreatic carcinogenesis.Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition.CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifenThe expression of Wnt-1 inducible signaling pathway protein-2 in astrocytoma: Correlation between pathological grade and clinical outcome.CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27(Kip1) via Skp2 and FOXO3a regulation.CCN5/WISP2 and metabolic diseases.CCN5 in alveolar epithelial proliferation and differentiation during neonatal lung oxygen injury.Racial disparity in breast cancer: can it be mattered for prognosis and therapy.Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.Detection of CCN1 and CCN5 mRNA in Human Cancer Samples Using a Modified In Situ Hybridization Technique.
P2860
Q33681837-2C18CC33-C1D2-4B4A-BA85-36BFA57E8D3DQ34526886-36484227-BE52-443D-B235-47280B032FA4Q36081385-EB8F2F7E-D736-4DAD-BEBB-06C5AFC591C5Q37301011-69E1E105-575E-41D3-9594-53A611B56A74Q37321763-3AB211FD-EB59-47CD-81F7-4B3C33754F7FQ37549104-A001215E-9E65-4D98-9C23-54FD523FC90AQ38323850-742735F3-6EDC-4BDC-B4D5-AA34E4E4DC9DQ38615651-F6E1F4E7-4E4C-47E3-B498-2E659B3B39F5Q38730332-CDC45930-2B5C-4AC1-8C44-64E2A6FD66FBQ38912741-A174C017-078B-4521-BBF7-9224D7712E22Q38931858-B2F11E1F-45AE-450F-8660-C506B39CEFABQ39010236-EF2EC202-C95F-445E-AA1C-02B8A5E06F66Q39267979-24ECB23A-1D81-4CD7-A1E9-F740BC863210Q40160860-AA3CE9FF-0438-4EC3-9042-2804FA85D3F1Q41505907-64B397F6-F380-4F17-B7A2-989E9585D9C9Q42579477-B68EE46C-7C21-4552-A70D-DFE0E53DBCB4Q44786986-CB784B19-706F-420E-BF36-04190224FF00Q47244341-529F4968-06FA-44CF-BAAD-E79478250CEBQ47653131-44464DEF-A888-471A-BC98-229182183F97Q47692378-19CF7E75-42B5-453C-AC2A-34193658FC66Q48261660-CF80E7A7-496A-495C-B982-6755C151196AQ51400186-9275B865-9BB2-4F26-AD70-FCF6E20D2932
P2860
CCN5/WISP-2: A micromanager of breast cancer progression
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
CCN5/WISP-2: A micromanager of breast cancer progression
@ast
CCN5/WISP-2: A micromanager of breast cancer progression
@en
type
label
CCN5/WISP-2: A micromanager of breast cancer progression
@ast
CCN5/WISP-2: A micromanager of breast cancer progression
@en
prefLabel
CCN5/WISP-2: A micromanager of breast cancer progression
@ast
CCN5/WISP-2: A micromanager of breast cancer progression
@en
P2860
P1476
CCN5/WISP-2: A micromanager of breast cancer progression
@en
P2093
Snigdha Banerjee
Sushanta K Banerjee
P2860
P2888
P356
10.1007/S12079-012-0158-2
P577
2012-04-10T00:00:00Z